Washington, 31 July 2026
The Trump administration has terminated a Medicare drug subsidy program, hours before President Donald Trump announced a deal to bring Gaza under a new security arrangement that envisions Hamas disarming.
The Trump administration confirmed on Thursday that it has ended a long-running Medicare drug subsidy, a policy change that took effect this week. Officials framed the rollback as part of broader efforts to reduce government spending, which contributed to a recent downgrade in U.S. GDP figures.
The subsidy had helped offset medication costs for Medicare beneficiaries, and its termination is expected to ripple through pharmacy benefit managers, insurers and the drug supply chain. Lawmakers on Capitol Hill were notified of the change through a brief administrative notice, with no accompanying legislative debate.
According to a GDP report compiled by government statisticians, the change in economic output stemmed from a decrease in government spending and a surge in imports. The combination of lower federal outlays and higher import volumes pushed the second-quarter figure below analyst expectations.
